Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	74.95	182.11	150.92	515.73	115.88	-
Short-Term Investments	-	9.26	-	-	-	118.24
Trading Asset Securities	711.3	641.21	722.59	417.62	65.15	-
Cash & Short-Term Investments	786.25	832.58	873.51	933.35	181.03	118.24
Cash Growth	-7.70%	-4.69%	-6.41%	415.59%	53.10%	-19.52%
Accounts Receivable	77.81	36.68	22.63	7.68	9.59	3.62
Other Receivables	1.07	0.86	0.8	0.98	6.25	4.06
Receivables	78.88	37.54	23.43	8.66	15.84	7.68
Inventory	38.76	43.28	44.75	54.53	49.18	49.72
Other Current Assets	13.63	2.97	7.24	0.51	1.89	4.12
Total Current Assets	917.51	916.36	948.93	997.05	247.93	179.76
Property, Plant & Equipment	191.86	157.34	127.82	117.42	103.67	68.55
Long-Term Investments	-	-	16.59	17.35	19.81	22.51
Other Intangible Assets	22.67	23.03	23.79	24.24	23.97	25.15
Long-Term Deferred Tax Assets	8.07	8	9.91	9.29	5.09	5.31
Long-Term Deferred Charges	0.45	0.63	0.87	1.11	1.35	1.59
Other Long-Term Assets	20.97	14.66	0.55	0.02	1.06	9.26
Total Assets	1,162	1,120	1,128	1,166	402.89	312.15
Accounts Payable	10.88	1.31	3.64	4.28	2.47	2.12
Accrued Expenses	6.4	14.57	16.92	17.05	11.48	9.14
Current Portion of Leases	0.31	0.29	0.76	1.37	1.33	-
Current Income Taxes Payable	7.17	-	-	1.51	0.4	-
Current Unearned Revenue	2.92	2.2	2.93	1.99	1.44	3.25
Other Current Liabilities	4.28	1.24	0.75	0.68	0.53	0.44
Total Current Liabilities	31.95	19.62	24.99	26.87	17.65	14.95
Long-Term Leases	3.65	4	12.2	12.31	13.02	-
Long-Term Deferred Tax Liabilities	0.85	0.91	5.45	5.67	2.59	2.59
Total Liabilities	36.45	24.53	42.63	44.86	33.26	17.54
Common Stock	108.22	108.22	108.22	108.22	81.16	81.16
Additional Paid-In Capital	878.09	878.09	878.09	871.49	113.62	113.62
Retained Earnings	138.77	109.19	99.53	141.92	174.84	99.82
Total Common Equity	1,125	1,096	1,086	1,122	369.63	294.61
Shareholders' Equity	1,125	1,096	1,086	1,122	369.63	294.61
Total Liabilities & Equity	1,162	1,120	1,128	1,166	402.89	312.15
Total Debt	3.96	4.3	12.96	13.68	14.35	-
Net Cash (Debt)	782.28	828.28	860.55	919.66	166.68	118.24
Net Cash Growth	-7.68%	-3.75%	-6.43%	451.75%	40.97%	-19.52%
Net Cash Per Share	7.23	7.67	7.99	9.02	2.05	1.46
Filing Date Shares Outstanding	108.22	108.22	108.22	108.22	81.16	81.16
Total Common Shares Outstanding	108.22	108.22	108.22	108.22	81.16	81.16
Working Capital	885.56	896.74	923.94	970.18	230.29	164.82
Book Value Per Share	10.40	10.12	10.03	10.36	4.55	3.63
Tangible Book Value	1,102	1,072	1,062	1,097	345.66	269.46
Tangible Book Value Per Share	10.19	9.91	9.81	10.14	4.26	3.32
Buildings	-	121.51	64.9	60.97	58.87	58.87
Machinery	-	71.64	67.04	62.65	55.95	49.69
Construction In Progress	-	41.84	54.6	43.14	29.52	5.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.